Atopic diseases and upper respiratory infections.
This article reviews information on the topics of asthma, atopic dermatitis, food allergy, and upper respiratory infections. The asthma section provides an in-depth look at sociodemographic factors contributing to asthma morbidity and the barriers to asthma control. New findings on the triggers and therapies of atopic dermatitis and new articles on formula allergy and peanut allergy are presented. Recent publications in the areas of sinusitis and upper respiratory infections are also reviewed.
Lester
M R
MR
Fairfield County Allergy, Asthma & Immunology Associates, PC, Stamford, Connecticut, USA.
Schneider
L C
LC
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000485:Allergens; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001249:Asthma / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D003876:Dermatitis, Atopic / Q000276:immunology / Q000628:therapy; D005512:Food Hypersensitivity / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000517:prevention & control / Q000628:therapy*; D012141:Respiratory Tract Infections / Q000628:therapy*; D012852:Sinusitis / Q000188:drug therapy; D012959:Socioeconomic Factors
D000318:Adrenergic beta-Agonists; D000485:Allergens; D000900:Anti-Bacterial Agents